Mitochondria-targeted engineered peptide promotes myogenesis, mitigates fibrosis, and reduces inflammation in duchenne muscular dystrophy by suppressing mitoROS-mediated NF-κB activation
Fields of Study & Subjects
Muscle Physiology and Disorders
GDF15 and Related Biomarkers
Adipose Tissue and Metabolism
Publication details
- Journal / source
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Volume
- 310
- Pages
- 118777–118777
- Publication date
- 18 March 2026
- Language
- EN